EUA

NeoPlex COVID-19 Detection Kit

FDA Emergency Use Authorization · GeneMatrix, Inc. · Oct 12, 2022

Key facts

Product NeoPlex COVID-19 Detection Kit
Company GeneMatrix, Inc.
Product type Real-time RT-PCR, Multiple Targets
Date Oct 12, 2022
FDA page fda.gov

At a glance

  • 1–9 Authorization documents
  • 1–9 EUAs for this company

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Emergency Use Authorizations

Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.

Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date:

Browse all Emergency Use Authorizations